The invasion of malignant cells through the basement membrane is a critical step 
The interaction of malignant cells with basement membranes plays an important role in their metastatic spread.' 2 Invasive carcinomas, including colorectal carcinomas, are characterised by the loss of an intact basement membrane. Basement membranes are electron dense, 20-100 nm thick layers of which collagen type IV, heparan sulphate proteoglycan, nidogen, and laminin are the major known components. Laminin, their most prominent glycoprotein, exhibits a number of biological activities including promotion of attachment, migration, growth, and differentiation of certain cells. 3 These properties of laminin are related to its potential for cell binding. In this respect several cell surface laminin binding proteins have been characterised. The best known of these is a cell surface receptor with a molecular mass ranging between 65 000 and 72 000 D found in a variety of tissues and cell lines including tumour,' skeletal muscle,7 and placental cells. 8 There is evidence to suggest that other cell surface proteins with Mr of 120000 D and 180000 D"'0 respectively, and a cell surface protein with a M, of 140 000 D as a member of the integrin family of adhesion receptors" may also function as laminin receptors. Laminin is made up by one A-chain (Mr=440000), a Bl-chain and a B2-chain (Mr=2 10 000 D and 230 000 D, respectively).'2 13 In the cross-shaped structure of laminin each of the A-and B-chains forms one short arm, and the rest of the three chains together project down the long arm.'4" Immunological, electronmicroscopical and cell culture studies with laminin fragments have shown that the central part of the molecule is responsible for cell adhesion. 4 6 In addition to promoting cell adhesion central fragments of laminin also decrease the metastatic potential of tumour cells presumably by saturation of laminin receptors thought to be involved in tumour cell invasion through basement membranes. '7 Other functional domains of the laminin molecule have been described. Thus High titre antisera against mouse laminin and human 7-S collagen (long form) were produced using standard protocols.27 28 Antisera against laminin showed no cross reactivity with collagen type IV (7-S and NC-1 domains) by radioimmunoassays and affinity purified antibodies against human 7-S collagen (long form) have previously been shown to be monospecific.28 ADHESION 
Results

HT 29 CELLS PREFERENTIALLY ADHERE TO LAMININ
The adhesion of HT 29 cells to various substrates is remarkably different. Within three hours only 3% of the cells adhered to BSA in serum-free medium compared with 58% adhering to laminin. Interestingly, a significant adhesion was also observed to the interstitial collagen type III (35%), and to pepsin solubilised collagen type IV (lacking the carboxy terminal propeptide; 25%) (Fig 2) . An incubation period of six hours increased this rate on collagen type III and IV to 51% and 43%, respectively (Fig 2) . Under all experimental conditions, however, HT 29 cells showed a preference for laminin rather than for the collagens type III and IV. Addition of serum to the cell suspension before assaying attenuated the differences between substrates (data not shown). To test the dose response relationship for laminin-mediated adhesion of HT 29 cells, plates were coated with laminin solutions of different concentrations. Laminin up to 2 5 [tg/cm2 clearly stimulated cell adhesion after which a plateau was reached (data not shown). We also studied the adhesion of HT 29 cells to laminin in the presence of affinity purified antilaminin-and anti-collagen type IV-(7-S long domain) antibodies in order to prove the specificity of the laminin action. Anti-laminin antibodies were dose dependent inhibitory suggesting that this interaction is specific, while no significant effect was noted with anti-collagen type IV antibodies (data not shown). To more precisely define the HT 29 cell binding domain in the laminin molecule, we tested the effect of added laminin fragments P1, P2, or the synthetic peptide YIGSR (Fig 3) . Cell adhesion to laminin was strongly inhibited by the addition of laminin fragment P1 from the central core of the laminin molecule in a dose dependent manner whereas fragment P2 originating from the periphery of the short arms was ineffective at comparable concentration (Fig 3) . The inhibition with the pentapeptide YIGSR was about 10 000 fold less effective in molar terms than with fragment P1 (Fig 3) .
IDENTIFICATION OF LAMININ-BINDING PROTEINS BY IMMUNOBLOTTING
The presence of specific laminin binding com- (Fig 5a) and was saturable (Fig 5b) .
With 90 (4)% (mean (SD)) relative to binding of human P1 fragment, the murine fragment P1 bound comparatively well. Binding of equimolar amounts of murine laminin fragment P2 was only 11% (10)% (mean (SD)), that for fragments labelled murine laminin or murine fragment P1 (Fig 6) . Laminin fragment P2 was ineffective in inhibition of laminin P1 binding to immobilised cell membranes (Fig 6) supporting the data from cell adhesion assays. The synthetic peptide YIGSR inhibited only in a 1000-10000 fold molar excess over laminin fragment P1 (Fig 6) in accordance with its lack of inhibition of cell adhesion in vitro.
Discussion
The present study shows that the basement membrane glycoprotein laminin acts as a preferential substrate for attachment and spreading of human colon adenocarcinoma derived HT 29 cells. Pepsin soluble basement membrane collagen type IV and the interstitial collagen type III were less preferred substrates. Specificity of laminin as an adhesion molecule was shown by the ability of anti-laminin antibodies to prevent attachment and spreading of HT 29 Immunoblotting experiments on separated HT 29 cell membranes revealed two major laminin binding components with a Mr of 67 000 and 69 000 D as well as several minor bands with molecular weights of 72 000-100 000 and 110 000-150 000 D (Fig 4) . 
